Angiodynamics (ANGO) Revenue (2010 - 2026)

Angiodynamics' Revenue history runs 17 years deep, the most recent figure standing at $86.6 million for Q2 2026.

• Quarterly Revenue rose 8.05% year-over-year to $86.6 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $320.2 million (up 9.46% YoY) and the FY2026 annual result came in at $320.2 million, up 9.46% from the prior year.
• Revenue was $86.6 million for Q2 2026 at Angiodynamics, up from $78.4 million in the prior quarter.
• Across five years, Revenue topped out at $91.1 million in Q2 2023 and bottomed at $67.5 million in Q3 2024.
• A 5-year average of $78.7 million and a median of $78.9 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue increased 13.22% — and 2024, when it decreased 22.06%.
• Angiodynamics' Revenue stood at $85.4 million in 2022, then retreated by 7.44% to $79.1 million in 2023, then slipped by 7.88% to $72.8 million in 2024, then increased by 9.04% to $79.4 million in 2025, then grew by 9.03% to $86.6 million in 2026.
• Business Quant data shows ANGO's Revenue at $86.6 million in Q2 2026, $78.4 million in Q1 2026, and $79.4 million in Q4 2025.